Prostatype Genomics AB (PROGEN) — Free Cash Flow Generation Index
Latest as of June 2020:
0.94x
Prostatype Genomics AB (PROGEN) has a Free Cash Flow Generation Index of 0.94x as of June 2020. Free cash flow of Skr5.27 Million represents 1% of operating cash flow (Skr5.63 Million). Explore PROGEN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.94x
Free Cash Flow / Operating CF
Free Cash Flow
Skr5.27 Million
SEK
Operating Cash Flow
Skr5.63 Million
SEK
Capital Expenditures
Skr361.71K
SEK
Annual Free Cash Flow Generation for Prostatype Genomics AB (None–None)
Year-by-year Free Cash Flow Generation Index for Prostatype Genomics AB. Check PROGEN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).